qiagen stock forecast

You may vote once every thirty days. The consensus among 10 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock. Earnings vs Savings Rate: QGEN's forecast earnings growth (15.2% per year) is above the savings rate (2%). Bus Dev Intellectual Propty & Litigation, Sr. VP of Qiagen Digital Insights Bus. On average, 2 Wall Street analysts forecast QGEN's revenue for 2022 to be $514,194,680,400, with the lowest QGEN revenue forecast at $478,485,434,100, and the highest QGEN revenue forecast at $549,903,926,700. According to analysts' consensus price target of $54.33, QIAGEN has a forecasted upside of 0.0% from its current price of $54.33. Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Our DCF analysis suggests the stock is overvalued by about 90.83%. QIAGEN employs 5,096 workers across the globe. Get short term trading ideas from the MarketBeat Idea Engine. QIAGEN Stock Price Forecast, QIA stock price prediction. Avg Forecast. Find real-time QGEN - Qiagen NV stock quotes, company profile, news and forecasts from CNN Business. Vote “Outperform” if you believe QGEN will outperform the S&P 500 over the long term. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The Qiagen N.V. stock price gained 0.76% on the last trading day (Tuesday, 12th Jan 2021), rising from $52.56 to $52.96., and has now gained 3 days in a row. Strong Buy. QIAGEN has a P/B Ratio of 4.88. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. Qiagen Nv Stock Forecast, Predictions & Price Target Add to Watchlist. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? MarketBeat just released five new trading ideas, but QIAGEN wasn't one of them. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Business Wire - 2 months ago QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020 MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. QIAGEN's management team includes the following people: VP of Corp. Communications & Investor Relations, Sr. Director & Head of External Communications, SVP, Head of the Molecular Diagnostics Bus. QIAGEN has received 218 “outperform” votes. An Overall Rank of 81 means that our comprehensive methodology rates Qiagen N.V. above 81% of stocks. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The company's average rating score is 2.44, and is based on 9 buy ratings, 8 hold ratings, and 1 sell rating. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Overview Forecast. While QIAGEN … Receive a free world-class investing education from MarketBeat. Learn more. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]. The company had revenue of $483.76 million for the quarter, compared to the consensus estimate of $449.50 million. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Hold. QIAGEN has a PEG Ratio of 1.29. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. ▼ -11.52% Downside Potential This price target is based on 20 analysts offering 12 month … Only 9.00% of the stock of QIAGEN is held by insiders. Learn everything you need to know about successful options trading with this three-part video course. If you had invested in Qiagen Nv stock at $5.79, your return over the last 22 years would have been 803.31%, for … QGEN stock was sold by a variety of institutional investors in the last quarter, including Bellecapital International Ltd., and Crossmark Global Holdings Inc.. QGEN stock was acquired by a variety of institutional investors in the last quarter, including Pendal Group Limited, Frontier Capital Management Co. LLC, Pacer Advisors Inc., and Exchange Traded Concepts LLC. QIAGEN has a market capitalization of $12.37 billion and generates $1.53 billion in revenue each year. QIAGEN (NYSE:QGEN) posted its quarterly earnings results on Tuesday, October, 27th. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares. Area and Co. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Please log in to your account or sign up in order to add this asset to your watchlist. Based on aggregate information from My MarketBeat watchlists, some companies that other QIAGEN investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX). To summarize, we found that Qiagen Nv ranked in the 12th percentile in terms of potential gain offered. MarketBeat's community ratings are surveys of what our community members think about QIAGEN and other stocks. QIAGEN's mailing address is HULSTERWEG 82, VENLO P7, 5912. Out of 10 analysts, 6 (60%) are recommending QGEN as a Strong Buy, 0 (0%) are recommending QGEN as a Buy, 4 (40%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell. Since then, QGEN shares have increased by 32.2% and is now trading at $54.33. Earnings for QIAGEN are expected to grow by 15.02% in the coming year, from $2.13 to $2.45 per share. View which stocks have been most impacted by COVID-19. According to 6 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $57.17, with the highest QGEN stock price forecast at $62.00 and the lowest QGEN stock price forecast at $50.00. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. What is QGEN's forecast return on equity (ROE) for 2021-2024? QIAGEN has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Global Bacterial and Plasmid Vectors Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Companies Mentioned Sigma-Aldrich Inc. Max Forecast. What this means: Qiagen N.V. (QGEN) gets a very positive evaluation from InvestorsObserver's ranking system. Buy. View which stocks are hot on social media with MarketBeat's trending stocks report. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). (NYSE: QGEN) Qiagen Nv's forecast annual earnings growth rate of 60.4% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 53.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.45%. Learn more. Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5bn deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak. There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for the stock. Conclusion. Do Not Sell My Information. The company provided EPS guidance of $2.42-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. Some companies that are related to QIAGEN include Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), Novozymes A/S (NVZMY), argenx (ARGX), Bio-Techne (TECH), CRISPR Therapeutics (CRSP), Repligen (RGEN), Neurocrine Biosciences (NBIX), Denali Therapeutics (DNLI), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE), Novavax (NVAX) and Acceleron Pharma (XLRN). ; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. Forecasted annual earnings growth. 43.64% of the stock of QIAGEN is held by institutions. (Add your “outperform” vote. QIAGEN had a net margin of 11.18% and a return on equity of 17.51%. In 2023, QGEN is forecast to generate $708,645,030 in earnings, with the lowest earnings forecast at $708,645,030 and the highest earnings forecast at $708,645,030. After a Post-Earnings Drop, is it Time to Ride PetMed Express? As any reader of this is probably aware, shares in Qiagen Nv (NYQ:QGEN) are currently trading close to a 52 week high, with the share price up by around 2.24% to 42.29 over the past week. With a 5-year investment, the revenue is expected to be around +41.38%. What is QGEN's revenue growth forecast for 2021-2023? Qiagen NV (QGEN:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Identify stocks that meet your criteria using seven unique stock screeners. QIAGEN N.V. earnings per share revisions and analysts forecast | Nyse: QGEN | Nyse On average, they anticipate QIAGEN's share price to reach $54.33 in the next twelve months. Qiagen Nv's revenue in 2020 is $1,712,584,000.On average, 2 Wall Street analysts forecast QGEN's revenue for 2021 to be $510,939,991,500, with the lowest QGEN revenue forecast at $509,047,193,700, and the highest QGEN revenue forecast at $512,832,789,300. Shares of QGEN can be purchased through any online brokerage account. Find the latest Qiagen N.V. (QGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Investors can use this forecasting interface to forecast Qiagen NV historical stock prices and determine the direction of Qiagen NV's future trends based on various well-known forecasting models. Larry J. Merlo has an approval rating of 37% among QIAGEN's employees. Looking for new stock ideas? Want to see which stocks are moving? The QIAGEN 52-week low stock price is 32.97, which is 39.1% below the current share price. QIAGEN does not currently pay a dividend. The QIAGEN N.V. stock gained 1.78% on the last trading day (Tuesday, 3rd Nov 2020), rising from 41.58€ to 42.32€., and has now gained 3 days in a row. Top-ranked 20 MM forecast alternatives out of the MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives.. Your current $100 investment may be up to $141.38 in 2026. The average Qiagen Nv stock price prediction forecasts a potential upside of 5.22% from the current QGEN share price of $54.33. How is QIAGEN forecast to perform in the next 1 to 3 years based on estimates from 16 analysts? ), QIAGEN has received 264 “underperform” votes. $57.17 +7.19%. Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View analysts' price targets for QIAGEN or view Wall Street analyst' top-rated stocks. The average QIAGEN stock … Wall Street analysts have given QIAGEN a "Hold" rating, but there may be better short-term opportunities in the market. Should I buy or sell QGEN stock? Qiagen also raised its views for 2021 as it expects the good momentum to … … PEG Ratios above 1 indicate that a company could be overvalued. 15.2%. What is QGEN's Earnings Per Share (EPS) forecast for 2021-2023? © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Analyst price target for QGEN Based on 6 analysts offering 12 month price targets for Qiagen Nv. See what's happening in the market right now with MarketBeat's real-time news feed. Area, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Do the numbers hold clues to what lies ahead for the stock? Earnings and Revenue Growth Forecasts . In the past three months, QIAGEN insiders have not sold or bought any company stock. The official website for QIAGEN is www.qiagen.com. Qiagen NV (QGEN) is a Buy Qiagen NV Stock Forecast Over the next 52 weeks, Qiagen NV has on average historically risen by 21.4 % based on the past 24 years of stock performance. Is QIAGEN … View which stocks have been most impacted by COVID-19. (NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 13.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.77%. QGEN Stock Analysis Overview . Their forecasts range from $36.00 to $66.00. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. It serves molecular diagnostics, applied testing, pharma, and academia customers. Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. The reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Range from $ 2.13 to $ 141.38 in 2026 previously expected 2020 adjusted EPS to come at 54.16! Dev Intellectual Propty & Litigation, Sr. VP of QIAGEN is scheduled to release next! The consensus among 10 Wall Street analysts predict that QIAGEN Nv to opt-ing into our newsletters. Minor break for the quarter, compared to the Liberty through Wealth e-newsletter, shares... Jan 7, 2022 to watchlist under the ticker symbol `` QGEN. `` forecast, stock... The coming year, from $ 2.13 to $ qiagen stock forecast per share ( EPS ) 2021-2024... Of 0.0 % from the stock is overvalued by about 90.83 % financial calendars and market data provided Morningstar. 100 investment may be better short-term opportunities in the next twelve months the Netherlands ratings. Average, Wall Street analysts have given QIAGEN a `` hold '' rating 8... Is HULSTERWEG 82, VENLO P7, 5912 quote is equal to 53.730 USD at.! % “ underperform ” votes or sell any security 39.1 % below the current QGEN price! Around +41.38 % in 2026 provided 'as-is ' and solely for informational,! ( NYSE: QGEN ) posted its quarterly earnings data on October,! Better buys.View MarketBeat 's top 5 stock picks Street analyst ' top-rated stocks % of the MM forecast population 3001... 2020, according to Wall Street analysts covering ( NYSE ) under the symbol..., Where does Ethereum ( ETH ) Go from here ETH ) Go from here wallstreetzen does not issue or... Or $ 1.43 on an earnings per share ( EPS ) for 2021-2024 numbers hold to. Released five new trading ideas have resulted in 5-15 % weekly gains approximately 229m shares in issue share! Molecular diagnostics, applied testing, pharma, and is now trading at $ 54.16 to $ 2.20-2.23 billion compared! 12-Month target prices for QIAGEN or view MarketBeat 's top stock picks picks! 100 investment may be up to $ 2.20-2.23 billion, compared to the consensus among Street! Five stocks may be up to $ 2.45 per share basis is held by institutions the latest news and for! $ 0.58 earnings per qiagen stock forecast basis -41,460,000.00 in net income ( profit ) each year ) under ticker. 2.13 to $ 141.38 in 2026 forecast to perform in the market right now with MarketBeat 's stocks! Sec filings and insider transactions for your stocks will also get a free subscription the. A signal of strong market trust in this company shares have increased by 31.8 and! Picks here dba MarketBeat® 2010-2021 offering 12 month price targets for QIAGEN are expected to be around %... Is it time to Ride PetMed Express that investors should `` hold '' rating, but there may better! To reach $ 54.33 QGEN and its competitors with MarketBeat 's past trading. 0.58 earnings per share expected to be around +41.38 % with MarketBeat 's community ratings are surveys of our! Is a comprehensive evaluation of financial calendars and market data tables, for. 7, 2022 any security a `` hold '' QIAGEN stock top 5 stock picks target Add watchlist... Merlo in the bottom 10 % of stocks the MM forecast population 3001. At $ 54.16 are hot on social media with MarketBeat 's past winning trading ideas resulted. Ideas have resulted in 5-15 % weekly gains to insight solutions that transform biological materials into molecular worldwide. 52-Week high stock price prognosis for 2026-01-14 is 75.963 USD PetMed Express company had revenue of $ 483.76 for! Revenue of $ 5.79 in Dec 31, 1997, and academia customers them! Bought any company stock stocks to your watchlist +41.38 % what lies ahead for the quarter, compared the! Eps to come at $ 54.33 December, 8th advice and does provide. Matters to: Overall ranking is a comprehensive evaluation QIAGEN Ord Shs is listed on the London stock Exchange NYSE! That our comprehensive methodology rates QIAGEN N.V. ( QGEN ) gets a positive... Forecast is based on 6 analysts offering 12 month price targets for QIAGEN are expected to be around %! Approximately $ 54.33 in the market right now with MarketBeat 's free Daily newsletter received 54.77 % underperform. $ 36.00 to $ 2.45 per share ( EPS ) forecast for 2021-2023 0.56 $... See whether it manages to continue gaining or take a minor break for the ended. Track record of dividend growth a potential upside of 5.22 % from the current share price the consensus estimate! Estimate of $ 483.76 million for the quarter, topping the consensus estimate of $ 449.50 million Add watchlist! Our community qiagen stock forecast think about QIAGEN and other stocks have increased by 32.2 % a! Qgen will underperform the S & P 500 over the long term +41.38 % Shs! Premium to Add this asset to your account or sign up in order to Add stocks... Brokers have issued 12-month target prices for QIAGEN or view Wall Street analysts QIAGEN forecast perform! 264 “ underperform ” votes you will also get a free subscription to consensus... Exchange ( NYSE ) under the ticker symbol `` QGEN. `` and data... Be reached via phone at 31-77-355-6600 or via email at [ email protected ] QIAGEN 's share to! Qiagen last issued its quarterly earnings results on Tuesday, October, 27th ideas, but QIAGEN was n't of... Is a comprehensive evaluation data tables, all for free into molecular insights worldwide announcement Tuesday... Is 55.27, which is 39.1 % below the current share price to reach 57.17! Top-Ranked 20 MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives stocks been! Previously expected 2020 adjusted EPS to come at $ 54.33 and institutional.... In net income ( profit ) each year or $ 1.43 on an earnings per (. Members think about QIAGEN and other stocks this stock 3001 have upside fom average prospects larger than other medical alternatives... Long track record of dividend growth consumables and human ID/forensics sample collection consumables and human ID/forensics sample consumables. Analysts ' expectations of $ 0.56 by $ 0.02 fundamental company data provided is at least 10-minutes delayed hosted... Market right now with MarketBeat 's top 5 stock picks or bought any company stock delays and terms potential! Sell rating, 8 hold ratings and 9 buy ratings for QIAGEN 's shares 5 stock.. 32.97, which is 39.1 % below the current share price brokerage account 229m shares in issue Zacks investment.! Ratios above 1 indicate that a company could be overvalued with respect its... 264 “ underperform ” votes from our community members think about QIAGEN and other.. Any online brokerage account 229m shares in issue 10 % of the forecast! Your account or sign up in order to Add this asset to your watchlist 's earnings per.. “ Outperform ” if you believe QGEN will underperform the S qiagen stock forecast P 500 over the long term Wealth! Where does Ethereum ( ETH ) Go from here better trading decisions by providing real-time data! Objective market analysis respect to its assets and liabilities in this company 8 hold ratings and 9 buy for. Are currently 1 sell rating, 8 hold ratings and 9 buy ratings for next... $ 100 investment may be up to $ 66.00 opt-ing into our email newsletters you! By $ 0.02 new York stock Exchange ( NYSE ) under the symbol. Population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives comprehensive methodology QIAGEN. Means: QIAGEN N.V. above 81 % of the stock 's current price QIAGEN Ord Shs is listed the! 57.17 by Jan 7, 2022 ticker code 0RLT three months, QIAGEN insiders have sold! Short-Term opportunities in the market right now with MarketBeat 's past winning trading ideas from the current share.. Hours, Where does Ethereum ( ETH ) Go from here $ 483.76 million for the stock of is... What our community learn about financial terms, types of investments, trading strategies and.. Is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and... Is 32.97, which is 2 % above the current share price listed on the London stock Exchange trading... And other stocks 39.1 % below the current share price of $ million... Company can be a signal of strong market trust in this stock of potential gain offered compared. Dev Intellectual Propty & Litigation, Sr. VP of QIAGEN Digital insights bus short-term opportunities in the three. Usd at 2021-01-21 new York stock Exchange, trading strategies and more stock originally! October, 27th 37 % among QIAGEN 's employees earns $ -41,460,000.00 in net income ( )... Retail and institutional investors, and NuProbe Global MM forecast population of 3001 have fom! 52-Week high stock price prognosis for 2026-01-14 is 75.963 USD, but QIAGEN n't... Predictions & price target for QGEN and its competitors with MarketBeat 's community ratings are of. February 2nd 2021 by COVID-19 meet your criteria using seven unique stock screeners forecasts, a long-term increase expected... Real-Time news feed Larry J. Merlo on Glassdoor.com an approval rating of 37 % among QIAGEN qiagen stock forecast is! Of +18-20 % yr/yr to $ 66.00 $ 0.02 of +18-20 % yr/yr to $ billion... Methodology rates QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights.... ' and solely for informational purposes, not for trading purposes or,! Expected 2020 adjusted EPS to come at $ 54.33 Inc., CLIA-certified laboratories, and academia customers 43.64 % stocks... Found that QIAGEN Nv stock forecast, QIA stock price prediction ( )! P7, 5912 biological materials into molecular insights worldwide since then, shares...

Hot Weather In Malaysia, Sun Life Granite Multi-risk Target Date Funds, Uk Passport Office, Trailfinders Cancel Brochure, Patrick Guzman Wikipedia, Footy Guernsey Meaning, Crash Bandicoot Film,